Search Results - "Kintzel, Polly E."

Refine Results
  1. 1

    Elotuzumab: Empiric analysis of dexamethasone administration schedule by Kintzel, Polly E

    Published in Journal of oncology pharmacy practice (01-01-2024)
    “…Elotuzumab in combination with dexamethasone and immunomodulating agents (IMiDs) lenalidomide or pomalidomide is 2nd to 4th line therapy for multiple myeloma…”
    Get full text
    Journal Article
  2. 2

    Carboplatin desensitization – simplified 4-step 2-bag method by Kintzel, Polly E, Gressel, Gregory M, Van Rossum, Brett T, Hillaker, Kristin N, Ice, Lauren L, Eastman, Jacqueline J

    Published in Journal of oncology pharmacy practice (01-06-2024)
    “…Introduction Our cancer program adopted a method for carboplatin desensitization (4-step 2-bag method) that administers the same intensity of drug exposure…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5
  6. 6

    Anticholinergic medications for managing noisy respirations in adult hospice patients by Kintzel, Polly E, Chase, Sandra L, Thomas, Wendy, Vancamp, Diane M, Clements, Elizabeth A

    Published in American journal of health-system pharmacy (01-03-2009)
    “…Anticholinergic medications for reducing noisy respirations in adult hospice patients are evaluated. Anticholinergic medications used to reduce noisy…”
    Get full text
    Journal Article
  7. 7

    Anticancer drug-induced kidney disorders: Incidence, prevention and management by KINTZEL, Polly E

    Published in Drug safety (2001)
    “…Nephrotoxicity is an inherent adverse effect of certain anticancer drugs. Renal dysfunction can be categorised as prerenal uraemia, intrinsic damage or…”
    Get full text
    Journal Article
  8. 8

    Increased Risk of Metabolic Syndrome, Diabetes Mellitus, and Cardiovascular Disease in Men Receiving Androgen Deprivation Therapy for Prostate Cancer by Kintzel, Polly E., Chase, Sandra L., Schultz, Lisa M., O'Rourke, Timothy J.

    Published in Pharmacotherapy (01-12-2008)
    “…Prostate cancer is the leading cancer diagnosis and second leading cause of cancer‐related mortality for men in the United States. Due to the increased…”
    Get full text
    Journal Article
  9. 9

    Stability of i.v. admixture containing metoclopramide, diphenhydramine hydrochloride, and dexamethasone sodium phosphate in 0.9% sodium chloride injection by KINTZEL, POLLY E, ZHAO, TING, WEN, BO, SUN, DUXIN

    Published in American journal of health-system pharmacy (01-12-2014)
    “…PURPOSEThe chemical stability of a sterile admixture containing metoclopramide 1.6 mg/mL, diphenhydramine hydrochloride 2 mg/mL, and dexamethasone sodium…”
    Get full text
    Journal Article
  10. 10

    Cost avoidance from dose rounding biologic and cytotoxic antineoplastics by Vandyke, Thomas H, Athmann, Paul W, Ballmer, Corey M, Kintzel, Polly E

    Published in Journal of oncology pharmacy practice (01-07-2017)
    “…Background To reduce product wastage, our institution allows automatic dose rounding of biologic and cytotoxic anticancer agents. The purpose of this project…”
    Get full text
    Journal Article
  11. 11

    Clofarabine‐Associated Acute Kidney Injury and Proteinuria by Kintzel, Polly E., Visser, James A., Campbell, Alan D.

    Published in Pharmacotherapy (01-09-2011)
    “…Clofarabine is used as second‐line therapy for acute myeloid leukemia. Acute renal impairment is reported with clofarabine; however, it is more likely to occur…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Pseudohyperkalemia in a patient with chronic lymphoblastic leukemia and tumor lysis syndrome by Kintzel, Polly E, Scott, William L

    Published in Journal of oncology pharmacy practice (01-12-2012)
    “…Purpose:Recognition of pseudohyperkalemia is essential to prevent medical mismanagement of erroneous hyperkalemia. The purpose of this case is to describe…”
    Get full text
    Journal Article
  14. 14

    Docetaxel-Associated Epiphora by Kintzel, Polly E., Michaud, Laura B., Lange, Marianne K.

    Published in Pharmacotherapy (01-06-2006)
    “…Docetaxel is a semisynthetic taxane indicated for the treatment of advanced breast, prostate, and non–small cell lung cancers; it is also used for the…”
    Get full text
    Journal Article
  15. 15

    Cost savings from dose rounding of biologic anticancer agents in adults by Winger, Brenda J, Clements, Elizabeth A, DeYoung, Jaculin L, O'Rourke, Timothy J, Claypool, Deborah L, Vachon, Steve, VanDyke, Thomas H, Zimmer-Young, Jennifer, Kintzel, Polly E

    Published in Journal of oncology pharmacy practice (01-09-2011)
    “…Purpose: The purpose of this project was to determine the cost savings related to a dose-rounding process for adult biologic anticancer agents. Methods:…”
    Get full text
    Journal Article
  16. 16

    Reduced time for urinary alkalinization before high-dose methotrexate with preadmission oral bicarbonate by Kintzel, Polly E, Campbell, Alan D, Yost, Kathleen J, Brinker, Brett T, Arradaza, Nicole V, Frobish, Daniel, Wehr, Alison M, O’Rourke, Timothy J

    Published in Journal of oncology pharmacy practice (01-06-2012)
    “…Purpose: Hydration and urinary alkalinization are essential for reducing renal dysfunction with high dose methotrexate (HDMTX). This report presents an…”
    Get full text
    Journal Article
  17. 17

    Improved pharmacy department workflow with new method of order entry for single-agent, high-dose methotrexate by Kintzel, Polly E, VanDyke, Thomas H, Athmann, Paul W, Mills, Lisa B, Bonter, Michael P, Bremer, Matthew W, Dougherty, Mary L, Foster, Ryan W, Knight, Sandra K, Slot, Martha G, Steinmetz-Malato, Laura L

    Published in Hospital pharmacy (Philadelphia) (01-12-2014)
    “…PURPOSETo determine whether a process change impacted the proportion of orders for single-agent, high-dose methotrexate entered by chemotherapy pharmacists…”
    Get full text
    Journal Article
  18. 18

    Improved Pharmacy Department Workflow with New Method of Order Entry for Single-Agent, High-Dose Methotrexate by Kintzel, Polly E., VanDyke, Thomas H., Athmann, Paul W., Mills, Lisa B., Bonter, Michael P., Bremer, Matthew W., Dougherty, Mary L., Foster, Ryan W., Knight, Sandra K., Slot, Martha G., Steinmetz-Malato, Laura L.

    Published in Hospital pharmacy (Philadelphia) (01-12-2014)
    “…Purpose To determine whether a process change impacted the proportion of orders for single-agent, high-dose methotrexate entered by chemotherapy pharmacists…”
    Get full text
    Journal Article
  19. 19

    Prophylaxis for paclitaxel hypersensitivity reactions by Kintzel, PE

    Published in The Annals of pharmacotherapy (01-09-2001)
    “…OBJECTIVE: To evaluate clinical literature supporting the prophylactic use of single-dose intravenous dexamethasone to prevent hypersensitivity reactions…”
    Get full text
    Journal Article
  20. 20